Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (561-570 of 573) with videos related to

Pageof 58
Sort By:
Cancer|September 23, 2025
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFTKarin Ribi, Bernard F Cole, Gini F Fleming, et al.
The New England Journal of Medicine|December 16, 2014
Adjuvant ovarian suppression in premenopausal breast cancerPrudence A Francis, Meredith M Regan, Gini F Fleming, et al.
The New England Journal of Medicine|June 3, 2014
Adjuvant exemestane with ovarian suppression in premenopausal breast cancerOlivia Pagani, Meredith M Regan, Barbara A Walley, et al.
Breast (Edinburgh, Scotland)|August 14, 2021
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancyAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young womenS J Luen, G Viale, S Nik-Zainal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization TrialMartine Piccart-Gebhart, Eileen Holmes, José Baselga, et al.
The New England Journal of Medicine|June 5, 2018
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast CancerPrudence A Francis, Olivia Pagani, Gini F Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE TrialFedro A Peccatori, Samuel M Niman, Ann H Partridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2024
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt PregnancyHatem A Azim, Samuel M Niman, Ann H Partridge, et al.
Breast (Edinburgh, Scotland)|July 31, 2025
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trialIsabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
Pageof 58

Showing results (561-570 of 573) with videos related to

Sort By:
Pageof 58
Cancer|September 23, 2025
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFTKarin Ribi, Bernard F Cole, Gini F Fleming, et al.
The New England Journal of Medicine|December 16, 2014
Adjuvant ovarian suppression in premenopausal breast cancerPrudence A Francis, Meredith M Regan, Gini F Fleming, et al.
The New England Journal of Medicine|June 3, 2014
Adjuvant exemestane with ovarian suppression in premenopausal breast cancerOlivia Pagani, Meredith M Regan, Barbara A Walley, et al.
Breast (Edinburgh, Scotland)|August 14, 2021
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancyAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young womenS J Luen, G Viale, S Nik-Zainal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization TrialMartine Piccart-Gebhart, Eileen Holmes, José Baselga, et al.
The New England Journal of Medicine|June 5, 2018
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast CancerPrudence A Francis, Olivia Pagani, Gini F Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE TrialFedro A Peccatori, Samuel M Niman, Ann H Partridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2024
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt PregnancyHatem A Azim, Samuel M Niman, Ann H Partridge, et al.
Breast (Edinburgh, Scotland)|July 31, 2025
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trialIsabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.
Pageof 58